Royal Philips Electronics today announced that mVisum, Inc.’s STEMI Alert smartphone app, will now work with Philips TraceMasterVue and IntelliSpace ECG management systems to gather data about patients having a heart attack in time to treat them and save their lives, by pushing information to physicians’ smartphones.
Heart attacks, sometimes called ST-elevation myocardial infarctions (STEMIs), occur when a blood clot clogs one of the coronary arteries, causing the muscle being supplied by that vessel to begin to die.
With heart attacks, patients must be treated within the first hour or two (sometimes called “the golden hour”), before there’s too much muscle damage and the heart can die. Identifying the symptoms quickly can speed treatment in that critical time.
mVisum’s STEMI Alert pulls together patient data surrounding an acute cardiac event and securely rushes it to physicians’ smartphones where it can be quickly viewed, assessed and responded to.
In 2008 over 616,000 people died of heart disease. Heart disease caused almost 25 percent of the deaths — almost one in every four — in the U.S. in that year. Cardiovascular disease is the biggest killer of those living in the U.S.
The mVisum STEMI Alert includes a patient electrocardiogram (ECG), which is acquired by the Philips PageWriter cardiograph and analyzed by the DXL ECG Algorithm, which uses sophisticated analytical methods for interpreting cardiac data.
The DXL Algorithm determines which ECGs are in need of clinical attention, and they are wirelessly transferred to the Philips TraceMasterVue or IntelliSpace ECG management system.
“These identified ECGs are then ‘pushed’ directly to the appropriate clinician’s smartphone via the Alert Platform, removing the need to travel to a review station, and helping clinicians to make faster, better-informed decisions when time is of the essence,” the press release reported, accelerating the information to physicians for immediate intervention that may save a life, or lessen the severity of the heart attack.
Edited by
Brooke Neuman
